Antimicrobial activity of oleanolic acid from Salvia officinalis and related compounds on vancomycin-resistant enterococci (VRIE)

被引：159

作者：

Horiuchi, Kumiko

Shiota, Sumiko

Hatano, Tsutomu

Yoshida, Takashi

Kuroda, Teruo

Tsuchiya, Tomofusa ^{[1
]}

机构：

[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Microbiol, Okayama 7008530, Japan

[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pharmacognosy, Okayama 7008530, Japan

[3] Shujitsu Univ, Sch Pharm, Dept Biol Pharm, Lab Pathogen Microbiol, Okayama 7038516, Japan

来源：

BIOLOGICAL & PHARMACEUTICAL BULLETIN | 2007年 / 30卷 / 06期

关键词：

oleanolic acid; ursolic acid; vancomycin-resistant enterococci (VRE); bactericidal activity; Sage;

D O I：

10.1248/bpb.30.1147

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

An extract from Salvia officinalis (Sage) leaves showed antimicrobial activity against vancomycin-resistant enterococci (VRE). We isolated the effective compound and identified it as oleanolic acid, a triterpenoid. We also tested antimicrobial activity of similar triterpenoids, ursolic acid, uvaol, betulinic acid and betulin. We found that ursolic acid also showed antimicrobial activity against VRE. The minimum inhibitory concentrations (MICs) of oleanolic acid and ursolic acid were 8 and 4 mu g/ml, respectively. These two compounds also showed antimicrobial activity against Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus (MRSA). These compounds showed bactericidal activity against VRE at least for 48 h when added at concentrations that were two-times higher than their MICs.

引用

页码：1147 / 1149

页数：3

共 50 条

[1] Vancomycin-Lipopeptide Conjugates with High Antimicrobial Activity on Vancomycin-Resistant Enterococci
Muehlberg, Eric
Umstaetter, Florian
Domhan, Cornelius
Hertlein, Tobias
Ohlsen, Knut
Krause, Andreas
Kleist, Christian
Beijer, Barbro
Zimmermann, Stefan
Haberkorn, Uwe
Mier, Walter
Uhl, Philipp
PHARMACEUTICALS, 2020, 13 (06)
[2] Antimicrobial activity of linezolid combined with minocycline against vancomycin-resistant Enterococci
WU Jing
JIANG Tian-tong
SU Jian-rong
LI Li
中华医学杂志（英文版）, 2013, 126 (14) : 2670 - 2675
[3] Antimicrobial activity of linezolid combined with minocycline against vancomycin-resistant Enterococci
Wu Jing
Jiang Tian-tong
Su Jian-rong
Li Li
CHINESE MEDICAL JOURNAL, 2013, 126 (14) : 2670 - 2675
[4] INDUCIBLE CARBOXYPEPTIDASE ACTIVITY IN VANCOMYCIN-RESISTANT ENTEROCOCCI
GUTMANN, L
BILLOTKLEIN, D
ALOBEID, S
KLARE, I
FRANCOUAL, S
COLLATZ, E
VANHEIJENOORT, J
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (01) : 77 - 80
[5] Emergence of vancomycin-resistant enterococci from vancomycin-susceptible enterococci in hospitalized patients under antimicrobial therapy
Janice, Jessin
Wagner, Theresa Maria
Olsen, Karina
Hegstad, Joachim
Hegstad, Kristin
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2024, 36 : 116 - 122
[6] Novel vancomycin dimers with activity against vancomycin-resistant enterococci
Sundram, UN
Griffin, JH
Nicas, TI
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (51) : 13107 - 13108
[7] Antimicrobial susceptibilities of clinical isolates of vancomycin-resistant enterococci in Taiwan
Hsueh, PR
Wu, JJ
Lu, JJ
Teng, LJ
Luh, KT
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1999, 98 (01) : 45 - 48
[8] Vancomycin-resistant enterococci in hemodialysis patients is related to intravenous vancomycin use
Fishbane, S
Cunha, BA
Mittal, SK
Ruggian, J
Shea, K
Schoch, PE
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (07): : 461 - 462
[9] Vancomycin-resistant enterococci: Risk related to the use of intravenous vancomycin.
Fuller, RE
Colvin, LG
Meredith, FT
Wilkinson, WE
Harrell, LJ
Sexton, DJ
CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 47 - 47
[10] In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci
Tong, Jiepeng
Jiang, Yiheng
Xu, Hao
Jin, Xuehang
Zhang, Li
Ying, Shuaibing
Yu, Wei
Qiu, Yunqing
DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 3049 - 3055

← 1 2 3 4 5 →